Filing Flows › Neuroone Medical Technologies (NMTC) › Q3 FY26 › vs Q2 FY26
Neuroone Medical Technologies (NMTC) Q3 FY26 vs Q2 FY26 (quarter over quarter)
Neuroone Medical Technologies's revenue rose $111K (+6%) from $1.9M in Q2 FY26 to $2.0M in Q3 FY26.
Neuroone Medical Technologies, Q3 FY26: revenue $2.0M (+16% year over year), operating margin -122.9%, net loss $2.0M, operating cash flow −$1.1M. The chart draws each line against Q2 FY26, the increases inside each band.
Every line
| Line | Q3 FY26 | Q2 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $2.0M | $1.9M | $111K | +6% |
| Other income, net | $418K | $15K | $403K | 28× |
| Net loss | $2.0M | $2.4M | −$376K | -16% |
| Costs & expenses | $4.4M | $4.3M | $138K | +3% |
| Operating costs | $4.4M | $4.3M | $138K | +3% |
| Cost of revenue | $790K | $872K | −$81K | -9% |
| Research & development | $1.4M | $1.5M | −$43K | -3% |
| SG&A | $2.2M | $1.9M | $262K | +14% |
| Operating cash sources | $2.0M | $2.4M | −$376K | -16% |
| Depreciation & amortization | $47K | $60K | −$13K | -22% |
| Share-based compensation | $353K | $342K | $11K | +3% |
| Working capital & other | $525K | $651K | −$126K | -19% |
| Cash used in operations | $1.1M | $1.3M | −$247K | -19% |
| Net loss absorbed | $2.0M | $2.4M | −$376K | -16% |
Questions
How much did Neuroone Medical Technologies's revenue grow quarter over quarter in Q3 FY26?
Neuroone Medical Technologies's revenue rose $111K (+6%) from $1.9M in Q2 FY26 to $2.0M in Q3 FY26.